266 related articles for article (PubMed ID: 11036934)
1. Chronic hypersecretion of luteinizing hormone in transgenic mice disrupts both ovarian and pituitary function, with some effects modified by the genetic background.
Nilson JH; Abbud RA; Keri RA; Quirk CC
Recent Prog Horm Res; 2000; 55():69-89; discussion 89-91. PubMed ID: 11036934
[TBL] [Abstract][Full Text] [Related]
2. Chronic hypersecretion of luteinizing hormone in transgenic mice selectively alters responsiveness of the alpha-subunit gene to gonadotropin-releasing hormone and estrogens.
Abbud RA; Ameduri RK; Rao JS; Nett TM; Nilson JH
Mol Endocrinol; 1999 Sep; 13(9):1449-59. PubMed ID: 10478837
[TBL] [Abstract][Full Text] [Related]
3. Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHbetaCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology.
Mann RJ; Keri RA; Nilson JH
Recent Prog Horm Res; 2003; 58():343-75. PubMed ID: 12795427
[TBL] [Abstract][Full Text] [Related]
4. High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene.
Mikola M; Kero J; Nilson JH; Keri RA; Poutanen M; Huhtaniemi I
Oncogene; 2003 May; 22(21):3269-78. PubMed ID: 12761497
[TBL] [Abstract][Full Text] [Related]
5. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors.
Risma KA; Clay CM; Nett TM; Wagner T; Yun J; Nilson JH
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1322-6. PubMed ID: 7877975
[TBL] [Abstract][Full Text] [Related]
6. Influence of mutations affecting gonadotropin production or responsiveness on expression of inhibin subunit mRNA and protein in the mouse ovary.
Hirst RC; Abel MH; Wilkins V; Simpson C; Knight PG; Zhang FP; Huhtaniemi I; Kumar TR; Charlton HM
Reproduction; 2004 Jul; 128(1):43-52. PubMed ID: 15232063
[TBL] [Abstract][Full Text] [Related]
7. Formation of cystic ovarian follicles associated with elevated luteinizing hormone requires estrogen receptor-beta.
Couse JF; Yates MM; Sanford R; Nyska A; Nilson JH; Korach KS
Endocrinology; 2004 Oct; 145(10):4693-702. PubMed ID: 15231698
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice.
Matzuk MM; DeMayo FJ; Hadsell LA; Kumar TR
Biol Reprod; 2003 Jul; 69(1):338-46. PubMed ID: 12672665
[TBL] [Abstract][Full Text] [Related]
9. Effects of gonadotropin-releasing hormone on pituitary-ovarian axis of one-year old pre-pubertal red seabream.
Kumakura N; Okuzawa K; Gen K; Yamaguchi S; Lim BS; Kagawa H
Gen Comp Endocrinol; 2004 Sep; 138(2):105-12. PubMed ID: 15302259
[TBL] [Abstract][Full Text] [Related]
10. The proximal promoter of the bovine luteinizing hormone beta-subunit gene confers gonadotrope-specific expression and regulation by gonadotropin-releasing hormone, testosterone, and 17 beta-estradiol in transgenic mice.
Keri RA; Wolfe MW; Saunders TL; Anderson I; Kendall SK; Wagner T; Yeung J; Gorski J; Nett TM; Camper SA
Mol Endocrinol; 1994 Dec; 8(12):1807-16. PubMed ID: 7708066
[TBL] [Abstract][Full Text] [Related]
11. Local production of the gonadotropic hormones in the rat ovary.
Schirman-Hildesheim TD; Gershon E; Litichever N; Galiani D; Ben-Aroya N; Dekel N; Koch Y
Mol Cell Endocrinol; 2008 Jan; 282(1-2):32-8. PubMed ID: 18248883
[TBL] [Abstract][Full Text] [Related]
12. Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-alpha knockout mouse.
Couse JF; Bunch DO; Lindzey J; Schomberg DW; Korach KS
Endocrinology; 1999 Dec; 140(12):5855-65. PubMed ID: 10579351
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin, steroid, and thyroid hormone milieu of young SWR mice bearing spontaneous granulosa cell tumors.
Beamer WG
J Natl Cancer Inst; 1986 Nov; 77(5):1117-23. PubMed ID: 3095581
[TBL] [Abstract][Full Text] [Related]
14. Hypothesis: aberrant puberty and the Stein-Leventhal syndrome.
Mechanick JI; Futterweit W
Int J Fertil; 1984; 29(1):35-8. PubMed ID: 6146582
[TBL] [Abstract][Full Text] [Related]
15. Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion.
Kero JT; Savontaus E; Mikola M; Pesonen U; Koulu M; Keri RA; Nilson JH; Poutanen M; Huhtaniemi IT
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E812-8. PubMed ID: 12773309
[TBL] [Abstract][Full Text] [Related]
16. Development of cystic glandular hyperplasia of the endometrium in Mullerian inhibitory substance type II receptor-pituitary tumor transforming gene transgenic mice.
El-Naggar SM; Malik MT; Martin A; Moore JP; Proctor M; Hamid T; Kakar SS
J Endocrinol; 2007 Jul; 194(1):179-91. PubMed ID: 17592032
[TBL] [Abstract][Full Text] [Related]
17. Ovarian stimulation with FSH in the rat reduces proestrous GnRH-dependent LH secretion through a dual mechanism: inhibition of LH synthesis and release.
Gordon A; Garrido-Gracia JC; Aguilar R; Sánchez-Criado JE
Neurosci Lett; 2009 Sep; 460(3):219-22. PubMed ID: 19477224
[TBL] [Abstract][Full Text] [Related]
18. No evidence for pituitary priming to gonadotropin-releasing hormone in relation to luteinizing hormone (LH) secretion prior to the preovulatory LH surge in ewes.
Crawford JL; McNeilly JR; McNeilly AS
Biol Reprod; 2004 Jul; 71(1):224-35. PubMed ID: 15031142
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice with chronically elevated luteinizing hormone are infertile due to anovulation, defects in uterine receptivity, and midgestation pregnancy failure.
Mann RJ; Keri RA; Nilson JH
Endocrinology; 1999 Jun; 140(6):2592-601. PubMed ID: 10342846
[TBL] [Abstract][Full Text] [Related]
20. Granulosa cell tumorigenesis in genetically hypogonadal-immunodeficient mice grafted with ovaries from tumor-susceptible donors.
Beamer WG; Shultz KL; Tennent BJ; Shultz LD
Cancer Res; 1993 Aug; 53(16):3741-6. PubMed ID: 8339285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
